High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial.

[1]  M. Hernán,et al.  Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.

[2]  L. Liang,et al.  Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial , 2018, Diabetologia.

[3]  Y. Hayashi,et al.  Regulation of amino acid metabolism and α‐cell proliferation by glucagon , 2018, Journal of diabetes investigation.

[4]  Chen Li,et al.  An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetes , 2017, Scientific Reports.

[5]  M. Patti,et al.  What Have Metabolomics Approaches Taught Us About Type 2 Diabetes? , 2016, Current Diabetes Reports.

[6]  Dolores Corella,et al.  Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions. , 2016, The American journal of clinical nutrition.

[7]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[8]  O. Fiehn,et al.  Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass. , 2015, Cell reports.

[9]  D. Corella,et al.  Benefits of the Mediterranean Diet: Insights From the PREDIMED Study. , 2015, Progress in cardiovascular diseases.

[10]  M. Qorbani,et al.  Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes. , 2015, Nutrition.

[11]  J. Shaw,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes Research and Clinical Practice.

[12]  Jussi Paananen,et al.  Hyperglycemia and a Common Variant of GCKR Are Associated With the Levels of Eight Amino Acids in 9,369 Finnish Men , 2012, Diabetes.

[13]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[14]  F. Folli,et al.  The potential role of glutamate in the current diabetes epidemic , 2012, Acta Diabetologica.

[15]  J. Holst,et al.  Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. , 2011, The Journal of nutrition.

[16]  Dolores Corella,et al.  A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. , 2011, The Journal of nutrition.

[17]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[18]  F. Levine,et al.  Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration. , 2010, The review of diabetic studies : RDS.

[19]  P. Maher,et al.  Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. , 2010, CNS & neurological disorders drug targets.

[20]  Dolores Corella,et al.  Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain , 2010, British Journal of Nutrition.

[21]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[22]  Ralph A. DeFronzo,et al.  From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus , 2009, Diabetes.

[23]  José Mataix Verdú,et al.  TABLA DE COMPOSICIÓN DE ALIMENTOS , 2009 .

[24]  J. Holst,et al.  Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. , 2009, The American journal of clinical nutrition.

[25]  Olli Simell,et al.  Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes , 2008, The Journal of experimental medicine.

[26]  R. Gougeon,et al.  The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. , 2006, Diabetes.

[27]  R. Curi,et al.  New Insights into Fatty Acid Modulation of Pancreatic β‐Cell Function , 2006 .

[28]  R. Curi,et al.  Glutamine and glutamate—their central role in cell metabolism and function , 2003, Cell biochemistry and function.

[29]  C. Wollheim,et al.  Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in Type II diabetes , 2000, Diabetologia.

[30]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.

[31]  F. Bellisle.  Glutamate and the UMAMI taste: sensory, metabolic, nutritional and behavioural considerations. A review of the literature published in the last 10 years , 1999, Neuroscience & Biobehavioral Reviews.

[32]  R. Elosua,et al.  Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. , 1994, American journal of epidemiology.

[33]  S. Schiffman,et al.  Effect of flavor enhancement of foods for the elderly on nutritional status: Food intake, biochemical indices, and anthropometric measures , 1993, Physiology & Behavior.

[34]  C. Betsholtz,et al.  Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. , 1993, The Journal of clinical investigation.

[35]  B. Rosner,et al.  Familial Clustering of Insulin Sensitivity , 1992, Diabetes.

[36]  F. Bellisle,et al.  Monosodium glutamate as a palatability enhancer in the european diet , 1991, Physiology & Behavior.